These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 17635058)

  • 1. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.
    Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH
    Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli.
    Hedrick TL; McElearney ST; Smith RL; Evans HL; Pruett TL; Sawyer RG
    Surg Infect (Larchmt); 2007 Dec; 8(6):589-97. PubMed ID: 18171118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
    Ghannam DE; Rodriguez GH; Raad II; Safdar A
    Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):253-9. PubMed ID: 18752007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit.
    Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P
    Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
    Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Aerosolized Antibiotics in Gram-Negative Ventilator-Associated Pneumonia in Trauma Patients.
    Gibson BH; Sharpe JP; Lewis RH; Newell JS; Swanson JM; Wood GC; Fabian TC; Croce MA; Magnotti LJ
    Am Surg; 2018 Dec; 84(12):1906-1912. PubMed ID: 30606347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
    Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
    J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteremia and ventilator-associated pneumonia: a marker for contemporaneous extra-pulmonic infection.
    Kunac A; Sifri ZC; Mohr AM; Horng H; Lavery RF; Livingston DH
    Surg Infect (Larchmt); 2014 Apr; 15(2):77-83. PubMed ID: 24192306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.
    Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG
    Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogen of ventilator-associated pneumonia does not influence the mortality rate of surgical intensive care unit patients treated with a rotational antibiotic system.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    Surg Infect (Larchmt); 2010 Feb; 11(1):13-20. PubMed ID: 20163258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
    Magnotti LJ; Schroeppel TJ; Clement LP; Swanson JM; Bee TK; Maish GO; Minard G; Zarzaur BL; Fischer PE; Fabian TC; Croce MA
    J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
    Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
    Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.